Preclinical development of kinetin as a safe error-prone SARS-CoV-2 antiviral able to attenuate virus-induced inflammation
Thiago Moreno L. Souza(National Institute of Science and Technology), Jaime A. Rabi(Department of Physiological Sciences)
Cited by 15
Related Papers
SARS-CoV-2 engages inflammasome and pyroptosis in human primary monocytes
|Cell Death Discovery|2021|274